Sign in
4

Changes in Ownership

Dermata Therapeutics, Inc. Filed Acc 0000905718-21-001165

Options or other derivatives

  • Chief Financial Officer acquired 75,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Van Hoose Kyri K. Chief Financial Officer 2021-09-01 Grant or award · Stock Option (right to Buy) +75,000 75,000 D: show line 1 in the form
Loading xslF345X03/dermata_fm4sep121.xml…